COVID-19 - May 30, 2023 - COVID-19 'bites the apple': Abdominal obesity ignites cytokine storm

Can't see this email? View it online

	COVID-19
	The latest COVID-19 news from News Medical

	COVID-19 'bites the apple': Abdominal obesity ignites cytokine storm Abdominal obesity increases the risk of severe COVID-19 and mortality due to heightened inflammatory responses, according to a study on Japanese patients and a murine COVID-19 model. Blocking inflammatory cytokines and preventing obesity may improve survival rates.

	Pawsitive test: Dogs sniff out COVID-19 with high accuracy, study shows Researchers conduct a systematic review to determine the potential of using canine olfactory senses as a screening tool for COVID-19.

			Is COVID-19 diagnosis associated with the risk and incidence of type 1 diabetes? Researchers assessed the incidence and risk of type 1 diabetes in children with coronavirus disease 2019.

			Large study uncovers new details about long COVID Initial findings from a study of nearly 10,000 Americans, many of whom had COVID-19, have uncovered new details about long COVID, the post-infection set of conditions that can affect nearly every tissue and organ in the body.

			Top-down proteomics: Bridging the genotype-to-phenotype gap In this interview conducted at Pittcon 2023 in Philadelphia, Pennsylvania, we spoke to this year's recipient of the Pittsburgh Analytical Chemistry Award, Neil Kelleher, about his work in top-down proteinomics.

			Study demonstrates that age and exercise increases aerosol particle emission Researchers evaluated the impact of age, body mass index, and gender on aerosol particles.

	National-level comprehensive mapping of high-fatality SARS-CoV-2 outbreaks in nursing homes Researchers analyzed data from three SARS-CoV-2 outbreaks among nursing homes in Belgium.

	Defining long-COVID using self-reported symptoms Researchers developed a symptom-based criteria to identify post-acute sequelae of SARS-CoV-2 infection.

	Exercise capacity found to be lower than expected among people with long COVID While some patients recover from the effects of SARS-CoV-2 infection, others have experienced the aftereffects of COVID-19 long after the initial infection. One of these long COVID symptoms is reduced exercise capacity.

	Is COVID-19 booster vaccination in early pregnancy associated with an increased risk of spontaneous abortion? Researchers studied the relationship between COVID-19 booster vaccination and spontaneous abortion.

	Critically ill corona patients benefit from COVID-19 vaccination Previous studies have shown that the mortality rate of Corona patients hospitalized and requiring oxygen therapy is similar no matter if they are vaccinated or unvaccinated.

	Study maps immune responses produced by COVID-19 vaccination in First Nations population Published in Nature Immunology and Nature Briefing, the research is the first of its kind to decisively map immune responses produced by a COVID-19 vaccination in any First Nations populations.

	What is the efficacy, safety, and tolerability of novel danuglipron in adults with type two diabetes? Researchers assessed the safety and efficacy of danuglipron in type 2 diabetes (T2D) patients.

	SARS-CoV-2 infection linked to increased risk of type 1 diabetes in children Different studies have documented an increased incidence of type 1 diabetes during the COVID-19 pandemic.

	MHRA authorizes new COVID-19 vaccine from SK Chemicals SKYCovion, the COVID-19 vaccine developed by SK Chemicals, has today been authorized by the Medicines and Healthcare products Regulatory Agency (MHRA).

	T-cell-inducing mRNA COVID-19 vaccine improves effectiveness Researchers develop a lipid nanoparticle-formulated mRNA-based antigen encoding three SARS-CoV-2 peptides derived from non-structural proteins.

	Oral antivirals Molnupiravir and Nirmatrelvir-Ritonavir lower COVID-19 risks in type 2 diabetes patients Research investigates the effectiveness of oral antiviral medications, Molnupiravir and Nirmatrelvir-Ritonavir, in treating patients with type 2 diabetes and mild to moderate COVID-19. The study aims to determine the efficacy of these medications in reducing adverse outcomes in this specific population.

	Research finds fever to be the most common non-respiratory feature of SARS-CoV-2 infection Fever was found to be the most common non-respiratory feature of infection with SARS-CoV-2, the virus that causes COVID-19, according to research published at the ATS 2023 International Conference.

	RECOVER study: An important step toward defining long COVID A study led by the National Institutes of Health's RECOVER Initiative and supported by NYU Langone Health, home to the effort's Clinical Science Core (CSC), provides an expanded working definition of long COVID.

	CDC reports on its Mpox response Research paper provides an overview of the U.S. monkeypox outbreak, highlighting the rapid response, vaccination efforts, and racial disparities in cases. Ongoing surveillance, vaccination, and communication are emphasized as crucial for future prevention.